BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22507205)

  • 1. A comparative study of backbone versus side chain peptide cyclization: application for HIV-1 integrase inhibitors.
    Hayouka Z; Levin A; Hurevich M; Shalev DE; Loyter A; Gilon C; Friedler A
    Bioorg Med Chem; 2012 May; 20(10):3317-22. PubMed ID: 22507205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein.
    Hayouka Z; Hurevich M; Levin A; Benyamini H; Iosub A; Maes M; Shalev DE; Loyter A; Gilon C; Friedler A
    Bioorg Med Chem; 2010 Dec; 18(23):8388-95. PubMed ID: 20974536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.
    Maes M; Levin A; Hayouka Z; Shalev DE; Loyter A; Friedler A
    Bioorg Med Chem; 2009 Nov; 17(22):7635-42. PubMed ID: 19850483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of backbone cyclic peptides bearing the arm domain of the HIV-1 Rev protein: characterization of the karyophilic properties and inhibition of Rev-induced gene expression.
    Hariton-Gazal E; Rosenbluh J; Zakai N; Fridkin G; Brack-Werner R; Wolff H; Devaux C; Gilon C; Loyter A
    Biochemistry; 2005 Aug; 44(34):11555-66. PubMed ID: 16114892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Backbone cyclic peptide inhibitors of protein kinase B (PKB/Akt).
    Tal-Gan Y; Hurevich M; Klein S; Ben-Shimon A; Rosenthal D; Hazan C; Shalev DE; Niv MY; Levitzki A; Gilon C
    J Med Chem; 2011 Jul; 54(14):5154-64. PubMed ID: 21650457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.
    Friedler A; Zakai N; Karni O; Broder YC; Baraz L; Kotler M; Loyter A; Gilon C
    Biochemistry; 1998 Apr; 37(16):5616-22. PubMed ID: 9548947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.
    de Soultrait VR; Caumont A; Parissi V; Morellet N; Ventura M; Lenoir C; Litvak S; Fournier M; Roques B
    J Mol Biol; 2002 Apr; 318(1):45-58. PubMed ID: 12054767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library.
    Armon-Omer A; Levin A; Hayouka Z; Butz K; Hoppe-Seyler F; Loya S; Hizi A; Friedler A; Loyter A
    J Mol Biol; 2008 Feb; 376(4):971-82. PubMed ID: 18201721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
    Gleenberg IO; Herschhorn A; Hizi A
    J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total synthesis, characterization, and conformational analysis of the naturally occurring hexadecapeptide integramide A and a diastereomer.
    De Zotti M; Damato F; Formaggio F; Crisma M; Schievano E; Mammi S; Kaptein B; Broxterman QB; Felock PJ; Hazuda DJ; Singh SB; Kirschbaum J; Brückner H; Toniolo C
    Chemistry; 2010 Jan; 16(1):316-27. PubMed ID: 19937615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple Hyp→Pro replacement in integramide A, a peptaib inhibitor of HIV-1 integrase: Effect on conformation and bioactivity.
    De Zotti M; De Borggraeve W; Kaptein B; Broxterman QB; Singh SB; Felock PJ; Hazuda DJ; Formaggio F; Toniolo C
    Biopolymers; 2011; 96(1):49-59. PubMed ID: 20560143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel method for the synthesis of urea backbone cyclic peptides using new Alloc-protected glycine building units.
    Hurevich M; Tal-Gan Y; Klein S; Barda Y; Levitzki A; Gilon C
    J Pept Sci; 2010 Apr; 16(4):178-85. PubMed ID: 20196085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
    King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
    J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: the melanocortin agonist paradigm.
    Ovadia O; Linde Y; Haskell-Luevano C; Dirain ML; Sheynis T; Jelinek R; Gilon C; Hoffman A
    Bioorg Med Chem; 2010 Jan; 18(2):580-9. PubMed ID: 20056544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
    Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
    Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
    Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
    J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
    J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR studies on Ni(II) induced cyclization of a histidine-tagged peptide.
    Spiga O; Bernini A; Scarselli M; Ciutti A; Giovannoni L; Laschi F; Bracci L; Niccolai N
    J Pept Sci; 2002 Nov; 8(11):634-41. PubMed ID: 12487431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.